Total Payments
$1,924
2024 Payments
$57.94
Companies
28
Transactions
111
Medicare Patients
7,746
Medicare Billing
$618,163
Payment Breakdown by Category
Food & Beverage$1,729 (89.9%)
Education$194.96 (10.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,729 | 103 | 89.9% |
| Education | $194.96 | 8 | 10.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $289.69 | 20 | $0 (2019) |
| C. R. Bard, Inc. & Subsidiaries | $200.35 | 7 | $0 (2024) |
| AbbVie, Inc. | $198.08 | 11 | $0 (2019) |
| PFIZER INC. | $194.50 | 8 | $0 (2019) |
| Janssen Biotech, Inc. | $141.42 | 9 | $0 (2019) |
| Dendreon Pharmaceuticals LLC | $128.59 | 6 | $0 (2019) |
| Ferring Pharmaceuticals Inc. | $121.62 | 8 | $0 (2019) |
| TOLMAR Pharmaceuticals, Inc. | $102.49 | 6 | $0 (2019) |
| Coloplast Corp | $95.01 | 7 | $0 (2019) |
| Aytu BioScience, Inc | $48.95 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $57.94 | 1 | C. R. Bard, Inc. & Subsidiaries ($57.94) |
| 2023 | $38.15 | 2 | C. R. Bard, Inc. & Subsidiaries ($38.15) |
| 2022 | $17.27 | 1 | Myriad Genetic Laboratories, Inc. ($17.27) |
| 2019 | $472.68 | 28 | Janssen Biotech, Inc. ($70.92) |
| 2018 | $606.14 | 38 | AbbVie, Inc. ($117.07) |
| 2017 | $731.86 | 41 | Astellas Pharma US Inc ($157.43) |
All Payment Transactions
111 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/31/2024 | C. R. Bard, Inc. & Subsidiaries | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $57.94 | General |
| Category: Urology | ||||||
| 11/01/2023 | C. R. Bard, Inc. & Subsidiaries | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $2.67 | General |
| Category: Urology | ||||||
| 10/23/2023 | C. R. Bard, Inc. & Subsidiaries | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $35.48 | General |
| Category: Urology | ||||||
| 09/20/2022 | Myriad Genetic Laboratories, Inc. | Prolaris (Device) | Food and Beverage | Cash or cash equivalent | $17.27 | General |
| Category: Gene Expression Analysis Oncology | ||||||
| 08/29/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Oncology | ||||||
| 08/07/2019 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $26.77 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 07/17/2019 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: ONCOLOGY | ||||||
| 07/01/2019 | Aytu BioScience, Inc | Natesto (Drug) | Food and Beverage | Cash or cash equivalent | $16.47 | General |
| Category: Urology | ||||||
| 06/26/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Oncology | ||||||
| 05/30/2019 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: ONCOLOGY | ||||||
| 05/30/2019 | Coloplast Corp | SPEEDICATH (Device) | Education | Cash or cash equivalent | $14.07 | General |
| Category: CONTINENCE | ||||||
| 05/23/2019 | AbbVie, Inc. | Lupron Depot (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Endocrinology | ||||||
| 05/22/2019 | TOLMAR Pharmaceuticals, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Prostate Cancer | ||||||
| 05/20/2019 | Aytu BioScience, Inc | Natesto (Drug) | Food and Beverage | Cash or cash equivalent | $15.64 | General |
| Category: Urology | ||||||
| 05/09/2019 | C. R. BARD, INC. & SUBSIDIARIES | — | Food and Beverage | In-kind items and services | $11.60 | General |
| 05/07/2019 | Sun Pharmaceutical Industries Inc. | YONSA (Drug) | Food and Beverage | Cash or cash equivalent | $15.60 | General |
| Category: Oncology | ||||||
| 04/30/2019 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: ONCOLOGY | ||||||
| 04/23/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Oncology | ||||||
| 04/08/2019 | Aytu BioScience, Inc | Natesto (Drug) | Food and Beverage | Cash or cash equivalent | $16.84 | General |
| Category: Urology | ||||||
| 04/03/2019 | Astellas Pharma US Inc | XTANDI (Drug), MYCAMINE | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: ONCOLOGY | ||||||
| 04/02/2019 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/01/2019 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 03/27/2019 | Osiris Therapeutics Inc. | Stravix (Biological), Grafix, GrafixPL | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Other Advanced Wound Management | ||||||
| 03/26/2019 | Sun Pharmaceutical Industries Inc. | YONSA (Drug) | Food and Beverage | Cash or cash equivalent | $19.34 | General |
| Category: Oncology | ||||||
| 03/21/2019 | C. R. BARD, INC. & SUBSIDIARIES | — | Food and Beverage | In-kind items and services | $13.87 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,787 | 5,028 | $408,728 | $145,858 |
| 2022 | 21 | 1,980 | 9,459 | $516,904 | $180,796 |
| 2021 | 24 | 2,086 | 6,827 | $576,828 | $187,110 |
| 2020 | 24 | 1,893 | 3,670 | $479,117 | $104,399 |
Total Patients
7,746
Total Services
24,984
Medicare Billing
$618,163
Procedure Codes
91
All Medicare Procedures & Services
91 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 191 | 274 | $55,348 | $26,073 | 47.1% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2023 | 42 | 741 | $58,539 | $25,482 | 43.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 293 | 347 | $47,539 | $20,924 | 44.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 63 | 80 | $47,360 | $14,356 | 30.3% |
| 87801 | Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | Office | 2023 | 42 | 165 | $26,070 | $11,351 | 43.5% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 49 | 51 | $45,849 | $10,469 | 22.8% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 48 | 49 | $23,569 | $6,155 | 26.1% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 44 | 86 | $17,974 | $5,942 | 33.1% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 44 | 1,965 | $11,651 | $4,250 | 36.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 29 | $12,006 | $3,222 | 26.8% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 14 | 14 | $8,133 | $2,692 | 33.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 31 | 36 | $7,668 | $2,209 | 28.8% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 46 | 46 | $8,418 | $2,041 | 24.2% |
| 87500 | Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | Office | 2023 | 42 | 57 | $4,503 | $1,960 | 43.5% |
| 87640 | Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | Office | 2023 | 42 | 57 | $4,503 | $1,960 | 43.5% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 200 | 237 | $5,925 | $1,926 | 32.5% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 14 | 14 | $6,656 | $1,585 | 23.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 428 | 651 | $3,255 | $1,432 | 44.0% |
| 51705 | Simple change of bladder tube | Office | 2023 | 19 | 21 | $4,893 | $1,074 | 22.0% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2023 | 47 | 49 | $7,497 | $586.99 | 7.8% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 36 | 36 | $1,188 | $88.98 | 7.5% |
| 81002 | Urinalysis, manual test | Office | 2023 | 23 | 23 | $184.00 | $75.39 | 41.0% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2022 | 44 | 871 | $66,820 | $30,139 | 45.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 339 | 390 | $53,430 | $24,490 | 45.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 148 | 234 | $47,268 | $21,976 | 46.5% |
About Dr. Arthur Wong, MD
Dr. Arthur Wong, MD is a Urology healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720180797.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arthur Wong, MD has received a total of $1,924 in payments from pharmaceutical and medical device companies, with $57.94 received in 2024. These payments were reported across 111 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($1,729).
As a Medicare-enrolled provider, Wong has provided services to 7,746 Medicare beneficiaries, totaling 24,984 services with total Medicare billing of $618,163. Data is available for 4 years (2020–2023), covering 91 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Providence, RI
- Active Since 09/01/2006
- Last Updated 07/22/2009
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1720180797
Products in Payments
- XTANDI (Drug) $318.83
- PROVENGE (Drug) $141.76
- FIRMAGON (Drug) $104.47
- ELIGARD (Drug) $102.49
- Erleada (Drug) $102.43
- Bard Urinary Drainage Bag (Device) $96.09
- Xtandi (Drug) $82.95
- Androgel (Drug) $81.17
- BMD-Bard Skylite (Device) $78.79
- Myrbetriq (Drug) $74.48
- SPEEDICATH (Device) $70.23
- Lupron (Drug) $62.96
- Natesto (Drug) $48.95
- Urgent PC (Device) $43.47
- ZYTIGA (Drug) $38.99
- CONTINENCE CARE (Device) $38.96
- Lupron Depot (Drug) $36.06
- YONSA (Drug) $34.94
- MYRBETRIQ (Drug) $29.25
- AVYCAZ (Drug) $28.89
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Providence
Joseph Renzulli, Md, MD
Urology — Payments: $319,986
Urology $319,986
Gyan Pareek, Md, MD
Urology — Payments: $159,818
Urology $159,818
Boris Gershman, M.d, M.D
Urology — Payments: $13,253
Urology $13,253
Dragan Golijanin, M.d, M.D
Urology — Payments: $12,359
Urology $12,359
Dr. Janice Santos Cortes, M.d, M.D
Urology — Payments: $12,283
Urology $12,283
Simone Thavaseelan
Urology — Payments: $11,331
Urology $11,331